169
Participants
Start Date
May 17, 2010
Primary Completion Date
October 19, 2011
Study Completion Date
November 23, 2015
pazopanib
oral anti-angiogenic treatment
sunitinib
oral anti-angiogenic treatment
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
Novartis Investigative Site, Caen
Novartis Investigative Site, Lahti
Novartis Investigative Site, Monza
Novartis Investigative Site, Turku
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Pavia
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Aviano (PN)
Novartis Investigative Site, Rennes
Novartis Investigative Site, Goslar
Novartis Investigative Site, Neuss
Novartis Investigative Site, Saint-Priest-en-Jarez
Novartis Investigative Site, Meldola (FC)
Novartis Investigative Site, Angers
Novartis Investigative Site, Aachen
Novartis Investigative Site, Bonn
Novartis Investigative Site, Lido Di Camaiore (LU)
Novartis Investigative Site, Mainz
Novartis Investigative Site, Pisa
Novartis Investigative Site, Lille
Novartis Investigative Site, Seinäjoki
Novartis Investigative Site, Vaasa
Novartis Investigative Site, Chieti
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Colmar
Novartis Investigative Site, Lyon
Novartis Investigative Site, Lecce
Novartis Investigative Site, Paris
Novartis Investigative Site, Rouen
Novartis Investigative Site, Joensuu
Novartis Investigative Site, Munich
Novartis Investigative Site, Hyères
Novartis Investigative Site, Ravensburg
Novartis Investigative Site, Fürth
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Helsinki
Novartis Investigative Site, Rome
Novartis Investigative Site, Taormina
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Bournemouth
Novartis Investigative Site, Cottingham
Novartis Investigative Site, Manchester
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Norwich
Novartis Investigative Site, Plymouth
Novartis Investigative Site, Preston
Novartis Investigative Site, Shrewsbury
Novartis Investigative Site, Wolverhampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY